GAUDIUMIVF NSE filing

Gaudium IVF Announces 11th AGM on Sep 28, 2026, to Discuss FY26 Financials and Director Re-appointment

The RealCase readMedium impact Neutral

Gaudium IVF will hold its 11th AGM on September 28, 2026, to adopt FY26 financial statements. Key agenda items include re-appointing Mr. Vishad Khanna, revising remuneration for Dr. Peeyush Khanna (₹48 Lakhs salary, ₹36 Lakhs consultancy) and Dr. Manika Khanna (₹1.8 Crore consultancy), and appointing secretarial auditors for five years.

Why it matters

The AGM addresses significant corporate governance matters including financial statement approval, director re-appointments, and remuneration changes for key management personnel. These decisions can have a material impact on the company's operations and investor relations.

The market read

The announcement is a routine corporate event (AGM notice) detailing financial statement adoption, director re-appointment, and remuneration adjustments. While these are important, they do not inherently signal a positive or negative shift in the company's outlook.

Gaudium IVF and Women Health Limited has announced its 11th Annual General Meeting (AGM) to be held on Monday, September 28, 2026, at 02:00 P.M. IST, through Video Conferencing (VC) / Other Audio-Visual Means (OAVM).

The primary agenda for the AGM includes the review and adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026. The meeting will also address the re-appointment of Mr. Vishad Khanna as a Non-Executive Director, who retires by rotation.

Furthermore, the AGM will seek shareholder approval for the revision in remuneration for Dr. Peeyush Khanna, Whole-Time Director, effective October 01, 2026, until December 10, 2029. This includes a revised annual salary of ₹48,00,000 and consultancy fees of ₹36,00,000.

Shareholders will also consider ratifying and approving the remuneration paid/payable to Dr. Manika Khanna, Chairperson and Managing Director, for her tenure up to September 19, 2027. Her remuneration includes consultancy fees of ₹1,80,00,000 per annum.

Additionally, the company proposes to appoint M/s. Suresh Nainwal & Company as Secretarial Auditors for a period of five consecutive years, from FY 2026-27 until FY 2030-31.

The Notice of the AGM, along with the Annual Report for FY 2025-26, will be sent via email to members registered by Friday, August 28, 2026. Remote e-voting will commence on Friday, September 25, 2026, and conclude on Sunday, September 27, 2026.

Primary source

A plain-language summary of a public exchange filing by Gaudium IVF and Women Health Limited. Read the original for the full detail.

View original filing
This is RealCase

Every move, explained.

Expert model portfolios with exact weights, an Active or Hold state on every holding, and a written reason behind every change. In your pocket.

Coming soon toApp StoreComing soon toGoogle Play
100% digital · your money stays in your own broker · your data is secure
RealCase
Your RealCases
Core Compounders
Stocks
13.4%
Flexi Core
Mutual Funds
13.1%
Latest change
ActiveHDFC Bank10% → 14%

“Deposits growing faster than loans again. We add on strength, funded from cash.”

₹0Commission · fee-only